RSLS Insider Trading

Insider Ownership Percentage: 0.10%
Insider Buying (Last 12 Months): $26,907.04
Insider Selling (Last 12 Months): $1,005.04

ReShape Lifesciences Insider Trading History Chart

This chart shows the insider buying and selling history at ReShape Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ReShape Lifesciences Share Price & Price History

Current Price: $0.17
Price Change: +0.30 (1.20%)
As of 04/24/2024 01:00 AM ET

This chart shows the closing price history over time for RSLS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ReShape Lifesciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/25/2023Thomas StankovichCFOSell131$0.27$35.3722,949View SEC Filing Icon  
10/11/2023Thomas StankovichCFOSell39$0.93$36.2723,080View SEC Filing Icon  
9/1/2023Thomas StankovichCFOSell118$0.89$105.0223,119View SEC Filing Icon  
8/24/2023Thomas StankovichCFOSell39$1.42$55.3823,237View SEC Filing Icon  
8/4/2023Thomas StankovichCFOSell108$1.43$154.4423,276View SEC Filing Icon  
7/6/2023Thomas StankovichCFOSell106$1.47$155.8223,384View SEC Filing Icon  
6/30/2023Thomas StankovichCFOBuy17,702$1.52$26,907.0423,490View SEC Filing Icon  
5/31/2023Thomas StankovichCFOSell98$2.41$236.185,788View SEC Filing Icon  
4/30/2023Thomas StankovichCFOSell96$2.36$226.565,886View SEC Filing Icon  
3/31/2023Thomas StankovichCFOSell109$2.60$283.405,982View SEC Filing Icon  
2/28/2023Thomas StankovichCFOSell103$4.25$437.756,091View SEC Filing Icon  
2/2/2023Thomas StankovichCFOSell157$13.29$2,086.536,194View SEC Filing Icon  
1/24/2023Thomas StankovichCFOSell158$7.49$1,183.426,351View SEC Filing Icon  
11/4/2022Thomas StankovichCFOSell167$13.50$2,254.506,655View SEC Filing Icon  
10/4/2022Thomas StankovichCFOSell165$14.00$2,310.006,773View SEC Filing Icon  
9/6/2022Thomas StankovichCFOSell96$19.50$1,872.006,939View SEC Filing Icon  
8/5/2022Barton P. BandyCEOSell233$23.50$5,475.5015,461View SEC Filing Icon  
8/5/2022Thomas StankovichCFOSell94$23.50$2,209.007,035View SEC Filing Icon  
7/1/2022Barton P. BandyCEOSell228$27.50$6,270.0015,695View SEC Filing Icon  
7/1/2022Thomas StankovichCFOSell92$27.50$2,530.007,130View SEC Filing Icon  
6/1/2022Barton P. BandyCEOSell226$47.50$10,735.0015,924View SEC Filing Icon  
5/31/2022Thomas StankovichCFOBuy400$46.00$18,400.007,312View SEC Filing Icon  
4/1/2022Barton P. BandyCEOSell221$56.50$12,486.5016,378View SEC Filing Icon  
4/1/2022Thomas StankovichCFOSell100$56.50$5,650.007,003View SEC Filing Icon  
1/31/2022Barton P. BandyCEOSell166$61.00$10,126.00View SEC Filing Icon  
1/31/2022Thomas StankovichCFOSell73$61.00$4,453.00View SEC Filing Icon  
1/4/2022Barton P. BandyCEOSell143$89.50$12,798.50View SEC Filing Icon  
1/4/2022Thomas StankovichCFOSell63$89.00$5,607.00View SEC Filing Icon  
12/2/2021Barton P. BandyCEOSell268$91.50$24,522.00View SEC Filing Icon  
12/2/2021Thomas StankovichCFOSell86$91.50$7,869.00View SEC Filing Icon  
11/18/2021Thomas StankovichCFOBuy400$101.00$40,400.00View SEC Filing Icon  
11/2/2021Barton P. BandyCEOSell270$134.50$36,315.00View SEC Filing Icon  
11/2/2021Thomas StankovichCFOSell86$134.50$11,567.00View SEC Filing Icon  
10/1/2021Barton P. BandyCEOSell251$138.50$34,763.50View SEC Filing Icon  
10/1/2021Thomas StankovichCFOSell73$138.00$10,074.00View SEC Filing Icon  
9/10/2021Barton P. BandyCEOSell5,889$144.50$850,960.5019,202View SEC Filing Icon  
9/10/2021Dan W. GladneyDirectorSell4,000$149.50$598,000.00View SEC Filing Icon  
9/10/2021Thomas StankovichCFOSell967$144.50$139,731.506,319View SEC Filing Icon  
8/30/2021Thomas StankovichCFOBuy300$171.50$51,450.00652View SEC Filing Icon  
8/20/2021Thomas StankovichCFOBuy300$161.00$48,300.00352View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for ReShape Lifesciences (NASDAQ:RSLS)

22.06% of ReShape Lifesciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RSLS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ReShape Lifesciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Armistice Capital LLC188,000$64K0.0%N/A5.449%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP36,490$43K0.0%N/A0.196%Search for SEC Filing on Google Icon
11/15/2021Sassicaia Capital Advisers LLC10,000$29K0.1%N/A0.063%Search for SEC Filing on Google Icon
8/17/2021Armistice Capital LLC816,527$4.08M0.1%N/A24.447%Search for SEC Filing on Google Icon
8/16/2021State Street Corp109,999$0.55M0.0%N/A3.293%Search for SEC Filing on Google Icon
8/13/2021Alpine Global Management LLC17,000$85K0.0%N/A0.509%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC23,277$0.12M0.0%N/A0.697%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.51,120$0.26M0.0%N/A1.531%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ReShape Lifesciences logo
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Read More on ReShape Lifesciences

Today's Range

Now: $0.17
Low: $0.17
High: $0.17

50 Day Range

MA: $0.17
Low: $0.15
High: $0.19

52 Week Range

Now: $0.17
Low: $0.14
High: $2.80

Volume

116,640 shs

Average Volume

740,701 shs

Market Capitalization

$2.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22

Who are the company insiders with the largest holdings of ReShape Lifesciences?

ReShape Lifesciences' top insider shareholders include:
  1. Thomas Stankovich (CFO)
  2. Barton P Bandy (CEO)
Learn More about top insider investors at ReShape Lifesciences.